These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31820218)

  • 1. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.
    Lin LA; Brummett CM; Waljee JF; Englesbe MJ; Gunaseelan V; Bohnert ASB
    J Gen Intern Med; 2020 Feb; 35(2):420-427. PubMed ID: 31820218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective.
    Hansgen JP; Robertson ML; Verzino EM; Manning LM
    J Pharm Pract; 2024 Dec; 37(6):1291-1296. PubMed ID: 38685768
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
    Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Intern Med; 2024 Aug; 184(8):954-962. PubMed ID: 38884975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: a Retrospective Analysis.
    Stein BD; Smart R; Jones CM; Sheng F; Powell D; Sorbero M
    J Gen Intern Med; 2021 Oct; 36(10):2952-2957. PubMed ID: 33598891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
    Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
    J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions.
    Qeadan F; Madden EF
    Addiction; 2022 Feb; 117(2):457-471. PubMed ID: 34286895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
    Pizzicato LN; Johnson CC; Viner KM
    Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
    [No Abstract]   [Full Text] [Related]  

  • 10. Naloxone dispensing among the commercially insured population in the United States from 2015 to 2018.
    Dunphy C; Zhang K; Guy GP; Jones CM
    Prev Med; 2021 Dec; 153():106820. PubMed ID: 34599923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.
    Stein BD; Jones CM; Smart R; Sheng F; Sorbero M
    Drug Alcohol Depend; 2021 Apr; 221():108569. PubMed ID: 33578296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014-2018.
    Barenie RE; Gagne JJ; Kesselheim AS; Pawar A; Tong A; Luo J; Bateman BT
    Drug Saf; 2020 Jul; 43(7):669-675. PubMed ID: 32180134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose.
    Follman S; Arora VM; Lyttle C; Moore PQ; Pho MT
    JAMA Netw Open; 2019 May; 2(5):e193209. PubMed ID: 31050777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis.
    Hartmann RJ; Elder JD; Terrett LA
    CMAJ Open; 2021; 9(1):E79-E86. PubMed ID: 33514601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.
    Kilaru AS; Liu M; Gupta R; Perrone J; Delgado MK; Meisel ZF; Lowenstein M
    Am J Emerg Med; 2021 Sep; 47():154-157. PubMed ID: 33812332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose.
    Kispert D; Carwile JL; Silvia KB; Eisenhardt EB; Thakarar K
    J Gen Intern Med; 2020 May; 35(5):1603-1605. PubMed ID: 31625039
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
    Nguyen AP; Glanz JM; Narwaney KJ; Binswanger IA
    JAMA Netw Open; 2020 Mar; 3(3):e201018. PubMed ID: 32219404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations.
    Ellis MS; Kasper ZA; Gold M; Cicero TJ
    J Addict Med; 2023 Mar-Apr 01; 17(2):197-205. PubMed ID: 36148998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial.
    Binswanger IA; Rinehart D; Mueller SR; Narwaney KJ; Stowell M; Wagner N; Xu S; Hanratty R; Blum J; McVaney K; Glanz JM
    J Gen Intern Med; 2022 Aug; 37(11):2624-2633. PubMed ID: 35132556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.